These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 35066090)

  • 1. Factor VIII/protein C ratio independently predicts liver-related events but does not indicate a hypercoagulable state in ACLD.
    Scheiner B; Balcar L; Nussbaumer RJ; Weinzierl J; Paternostro R; Simbrunner B; Hartl L; Jachs M; Bauer D; Stättermayer AF; Semmler G; Pinter M; Ay C; Quehenberger P; Trauner M; Reiberger T; Lisman T; Mandorfer M
    J Hepatol; 2022 May; 76(5):1090-1099. PubMed ID: 35066090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased factor VIII plays a significant role in plasma hypercoagulability phenotype of patients with cirrhosis.
    Sinegre T; Duron C; Lecompte T; Pereira B; Massoulier S; Lamblin G; Abergel A; Lebreton A
    J Thromb Haemost; 2018 Jun; 16(6):1132-1140. PubMed ID: 29577605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of ammonia levels on outcome in clinically stable outpatients with advanced chronic liver disease.
    Balcar L; Krawanja J; Scheiner B; Paternostro R; Simbrunner B; Semmler G; Jachs M; Hartl L; Stättermayer AF; Schwabl P; Pinter M; Szekeres T; Trauner M; Reiberger T; Mandorfer M
    JHEP Rep; 2023 Apr; 5(4):100682. PubMed ID: 36873421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severity of systemic inflammation is the main predictor of ACLF and bleeding in individuals with acutely decompensated cirrhosis.
    Zanetto A; Pelizzaro F; Campello E; Bulato C; Balcar L; Gu W; Gavasso S; Saggiorato G; Zeuzem S; Russo FP; Mandorfer M; Reiberger T; Trebicka J; Burra P; Simioni P; Senzolo M
    J Hepatol; 2023 Feb; 78(2):301-311. PubMed ID: 36150575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic inflammation increases across distinct stages of advanced chronic liver disease and correlates with decompensation and mortality.
    Costa D; Simbrunner B; Jachs M; Hartl L; Bauer D; Paternostro R; Schwabl P; Scheiner B; Stättermayer AF; Pinter M; Trauner M; Mandorfer M; Reiberger T
    J Hepatol; 2021 Apr; 74(4):819-828. PubMed ID: 33075344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An impaired pituitary-adrenal signalling axis in stable cirrhosis is linked to worse prognosis.
    Hartl L; Simbrunner B; Jachs M; Wolf P; Bauer DJM; Scheiner B; Balcar L; Semmler G; Schwarz M; Marculescu R; Trauner M; Mandorfer M; Reiberger T
    JHEP Rep; 2023 Aug; 5(8):100789. PubMed ID: 37484210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lower free triiodothyronine (fT3) levels in cirrhosis are linked to systemic inflammation, higher risk of acute-on-chronic liver failure, and mortality.
    Hartl L; Simbrunner B; Jachs M; Wolf P; Bauer DJM; Scheiner B; Balcar L; Semmler G; Schwarz M; Marculescu R; Dannenberg V; Trauner M; Mandorfer M; Reiberger T
    JHEP Rep; 2024 Jan; 6(1):100954. PubMed ID: 38125301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. von Willebrand factor and procoagulant imbalance predict outcome in patients with cirrhosis and thrombocytopenia.
    Kalambokis GN; Oikonomou A; Christou L; Kolaitis NI; Tsianos EV; Christodoulou D; Baltayiannis G
    J Hepatol; 2016 Nov; 65(5):921-928. PubMed ID: 27297911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of procoagulant imbalance. Modified endogenous thrombin potential with results expressed as ratio of values with-to-without thrombomodulin.
    Tripodi A
    Thromb Haemost; 2017 May; 117(5):830-836. PubMed ID: 28229158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Global hemostatic profiling in patients with decompensated cirrhosis and bacterial infections.
    Zanetto A; Campello E; Bulato C; Gavasso S; Saggiorato G; Shalaby S; Burra P; Angeli P; Senzolo M; Simioni P
    JHEP Rep; 2022 Jul; 4(7):100493. PubMed ID: 35647501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Procoagulant imbalance aggravated with falling liver function reserve, but not associated with the presence of portal vein thrombosis in cirrhosis.
    Tang W; Wang Y; Zhao X; Wang X; Zhang T; Ou X; Shou W; You H; Jia J
    Eur J Gastroenterol Hepatol; 2015 Jun; 27(6):672-8. PubMed ID: 25923942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance of substantially elevated von Willebrand factor antigen levels in patients with advanced chronic liver disease.
    Pomej K; Scheiner B; Balcar L; Nussbaumer RJ; Weinzierl J; Paternostro R; Simbrunner B; Bauer D; Pereyra D; Starlinger P; Stättermayer AF; Pinter M; Trauner M; Quehenberger P; Reiberger T; Mandorfer M
    Dig Liver Dis; 2022 Oct; 54(10):1376-1384. PubMed ID: 35871985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of a prothrombotic phenotype using thrombin generation and thrombin activity in cirrhosis and portal hypertension.
    Königsbrügge O; Scheiner B; Simbrunner B; Semmler G; Quehenberger P; Pabinger-Fasching I; Trauner M; Mandorfer M; Lisman T; Ay C; Reiberger T
    Thromb Res; 2023 Feb; 222():124-130. PubMed ID: 36646026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coagulopathy is not predictive of bleeding in patients with acute decompensation of cirrhosis and acute-on-chronic liver failure.
    Campello E; Zanetto A; Bulato C; Maggiolo S; Spiezia L; Russo FP; Gavasso S; Mazzeo P; Tormene D; Burra P; Angeli P; Senzolo M; Simioni P
    Liver Int; 2021 Oct; 41(10):2455-2466. PubMed ID: 34219335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. More Pronounced Hypercoagulable State and Hypofibrinolysis in Patients With Cirrhosis With Versus Without HCC.
    Zanetto A; Campello E; Bulato C; Gavasso S; Saggiorato G; Shalaby S; Spiezia L; Cillo U; Farinati F; Russo FP; Burra P; Senzolo M; Simioni P
    Hepatol Commun; 2021 Dec; 5(12):1987-2000. PubMed ID: 34558850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Procoagulant imbalance in patients with non-alcoholic fatty liver disease.
    Tripodi A; Fracanzani AL; Primignani M; Chantarangkul V; Clerici M; Mannucci PM; Peyvandi F; Bertelli C; Valenti L; Fargion S
    J Hepatol; 2014 Jul; 61(1):148-54. PubMed ID: 24657400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dysregulated biomarkers of innate and adaptive immunity predict infections and disease progression in cirrhosis.
    Simbrunner B; Hartl L; Jachs M; Bauer DJM; Scheiner B; Hofer BS; Stättermayer AF; Marculescu R; Trauner M; Mandorfer M; Reiberger T
    JHEP Rep; 2023 May; 5(5):100712. PubMed ID: 37035457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thromboelastometry in patients with advanced chronic liver disease stratified by severity of portal hypertension.
    Raeven P; Baron-Stefaniak J; Simbrunner B; Stadlmann A; Schwabl P; Scheiner B; Schaden E; Eigenbauer E; Quehenberger P; Mandorfer M; Baron DM; Reiberger T
    Hepatol Int; 2020 Dec; 14(6):1083-1092. PubMed ID: 33000389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prominent protein Z-induced thrombin inhibition in cirrhosis: a new functional assay for hypercoagulability assessment.
    Kim SY; Kim JE; Kim YJ; Han KS; Kim HK
    J Gastroenterol Hepatol; 2015 Apr; 30(4):784-93. PubMed ID: 25303721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Whole blood thrombin generation shows a significant hypocoagulable state in patients with decompensated cirrhosis.
    Zanetto A; Campello E; Bulato C; Willems R; Konings J; Roest M; Gavasso S; Nuozzi G; Toffanin S; Zanaga P; Burra P; Russo FP; Senzolo M; de Laat B; Simioni P
    J Thromb Haemost; 2024 Feb; 22(2):480-492. PubMed ID: 37866518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.